Annual Accounts Payable
$2.33 M
+$844.00 K+56.80%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual accounts payable is $2.33 million, with the most recent change of +$844.00 thousand (+56.80%) on December 31, 2023.
- During the last 3 years, EFTR annual accounts payable has risen by +$1.98 million (+571.47%).
- EFTR annual accounts payable is now at all-time high.
Performance
EFTR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.71 M
-$617.00 K-26.48%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly accounts payable is $1.71 million, with the most recent change of -$617.00 thousand (-26.48%) on March 31, 2024.
- Over the past year, EFTR quarterly accounts payable has dropped by -$2.08 million (-54.85%).
- EFTR quarterly accounts payable is now -54.85% below its all-time high of $3.79 million, reached on March 31, 2023.
Performance
EFTR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EFTR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.8% | -54.9% |
| 3 y3 years | +571.5% | -54.9% |
| 5 y5 years | +571.5% | -54.9% |
EFTR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +351.6% | -54.9% | +482.6% |
| 5 y | 5-year | at high | +571.5% | -54.9% | +482.6% |
| alltime | all time | at high | +571.5% | -54.9% | +482.6% |
EFFECTOR Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $1.71 M(-26.5%) |
| Dec 2023 | $2.33 M(+56.8%) | $2.33 M(+105.1%) |
| Sep 2023 | - | $1.14 M(-21.7%) |
| Jun 2023 | - | $1.45 M(-61.8%) |
| Mar 2023 | - | $3.79 M(+155.3%) |
| Dec 2022 | $1.49 M | $1.49 M(+22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.21 M(+0.8%) |
| Jun 2022 | - | $1.20 M(+309.5%) |
| Mar 2022 | - | $294.00 K(-43.0%) |
| Dec 2021 | $516.00 K(+48.7%) | $516.00 K(+60.7%) |
| Sep 2021 | - | $321.00 K(-7.5%) |
| Dec 2020 | $347.00 K | $347.00 K |
FAQ
- What is eFFECTOR Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual accounts payable year-on-year change?
- What is eFFECTOR Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly accounts payable year-on-year change?
What is eFFECTOR Therapeutics annual accounts payable?
The current annual accounts payable of EFTR is $2.33 M
What is the all time high annual accounts payable for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual accounts payable is $2.33 M
What is eFFECTOR Therapeutics annual accounts payable year-on-year change?
Over the past year, EFTR annual accounts payable has changed by +$844.00 K (+56.80%)
What is eFFECTOR Therapeutics quarterly accounts payable?
The current quarterly accounts payable of EFTR is $1.71 M
What is the all time high quarterly accounts payable for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly accounts payable is $3.79 M
What is eFFECTOR Therapeutics quarterly accounts payable year-on-year change?
Over the past year, EFTR quarterly accounts payable has changed by -$2.08 M (-54.85%)